for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Assertio Therapeutics Announces Repurchase Of About $188 Mln Of Its Outstanding Convertible Debt

Feb 19 (Reuters) - Assertio Therapeutics Inc:

* ASSERTIO THERAPEUTICS ANNOUNCES REPURCHASE OF APPROXIMATELY $188.0 MILLION OF ITS OUTSTANDING CONVERTIBLE DEBT

* ASSERTIO THERAPEUTICS - ENTERED PURCHASE AGREEMENTS OF CO’S OUTSTANDING 2.50% CONVERTIBLE NOTES DUE 2021 AND 5.00% CONVERTIBLE SENIOR NOTES DUE 2024 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up